Showing 3061-3070 of 3189 results for "".
Facial Skincare
https://practicaldermatology.com/topics/practice-management/facial-skincare/21228/Experts share insights on cosmeceutical and neutraceutical research and trends.Mohs Certification: A Call for Dialogue
https://practicaldermatology.com/topics/practice-management/mohs-certification-a-call-for-dialogue/21222/Completing the Picture: How Skincare and Device Based Treatments are Reshaping Facial Aesthetics
https://practicaldermatology.com/topics/general-topics/completing-the-picture-how-skincare-and-device-based-treatments-are-reshaping-facial-aesthetics/21229/Recently Passed Law Clears Way for New Sunscreen Ingredients
https://practicaldermatology.com/topics/skin-cancer-photoprotection/recently-passed-law-clears-way-for-new-sunscreen-ingredients/21232/By forcing the FDA to clear its backlog of sunscreen ingredients pending review, The Sunscreen Innovation Act is a major win for UV protection efforts.New products and pharmacologic developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21235/New Products
https://practicaldermatology.com/columns/new-products/new-products/21250/New products and pharmacologic developmentsNews
https://practicaldermatology.com/topics/general-topics/news/21281/The Molecular Era in Melanoma Treatment
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-molecular-era-in-melanoma-treatment/21296/New Products
https://practicaldermatology.com/columns/new-products/new-products/21316/Melanoma Treatment Landscape Evolves
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-treatment-landscape-evolves/21314/The first agent to target the PD-1 pathway, pembrolizumab may prolong life expectancy in some patients.